This Week in Nature

genomeweb
360dx

This Week in Nature

Feb 22, 2007

In today's copy of Nature, you'll find these items worth reading:

To read the full story....

...and receive Daily News bulletins.

Already have an account?
Login Now.

Breaking News

B. Braun China, CeGaT Collaborating on Clinical Genetic Testing Services in China
PathogenDx Closes $3.4M Convertible Note Round
Somalogic Licenses GNS Healthcare Machine Learning Tech
Locus Biosciences Acquires EpiBiome Bacteriophage Discovery Platform
NIH, Prostate Cancer Foundation Partner to Study Disease Aggressiveness in African Americans
Genetic Variant in Multiple Sclerosis Patients Associated With Treatment-Induced Liver Damage

The Scan

UK Bioethics Group Gives Cautious OK for Genetically Modifying Human Embryos

The UK's Nuffield Council on Bioethics says genetically modifying human embryos could be morally permissible, according to the Guardian.

CRISPR-Induced Damage?

A new Nature Biotechnology paper reports that CRISPR-Cas9 gene editing can lead to large deletions or complex rearrangements that could be pathogenic.

'Fax' It Over

The Wall Street Journal likens a prototype developed by Synthetic Genomics to a "biological fax machine."

This Week in PNAS

In PNAS this week: strategy for reactivating Rett syndrome-linked MECP2, small molecules able to suppress Staphylococcus aureus virulence, and more.

Main menu